1-{3-[3-tert-Butylsulfanyl-1-(4-chloro-benzyl)-5-isopropyl-1H-indol-2-yl]-2,2-dimethyl-propyl}-1-hydroxy-urea | 141862-64-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-{3-[3-tert-Butylsulfanyl-1-(4-chloro-benzyl)-5-isopropyl-1H-indol-2-yl]-2,2-dimethyl-propyl}-1-hydroxy-urea
• 英文别名: 1-[3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropyl]-1-hydroxyurea
• CAS: 141862-64-8
• 化学式: C₂₈H₃₈ClN₃O₂S
• 分子量: 516.148
• InChiKey: AIIZMHYSVIPRCK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  35
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  96.8
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-{3-[3-tert-Butylsulfanyl-1-(4-chloro-benzyl)-5-isopropyl-1H-indol-2-yl]-2,2-dimethyl-propyl}-1-hydroxy-urea 在 titanium(III) chloride 、 sodium acetate 作用下， 以 甲醇 为溶剂， 反应 24.0h， 生成 N-2,2-dimethyl-3-[(1-(4-chlorophenylmethyl)-3-(1,1-dimethylethyl-thio)-5-(1-methylethyl))indol-2-yl]propyl urea
  参考文献：
  名称：

  O-alkylcarboxylate oxime and N-hydroxyurea analogs of substituted indole leukotriene biosynthesis inhibitors

  摘要：

  Reference FLAP inhibitors 1 and 2 were converted into the corresponding O-acetic acid oxime congeners 8 and 11a, respectively, resulting in potent, orally active, leukotriene biosynthesis inhibitors. An attempt to create a dual FLAP and direct 5-LO inhibitor by replacing the carboxylate group in 1 with the N-hydroxyurea pharmacophore did not provide superior inhibitors. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00271-5
• 作为产物：
  描述：

  3-[1-(4-氯苄基)-3-叔丁基硫代-5-异丙基吲哚-2-基]-2,2-二甲基丙酸 在 草酰氯 、 吡啶硼烷 、 dimethyl sulfide borane 、 羟胺 作用下， 以 四氢呋喃 、 吡啶 、 乙醇 、 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 38.5h， 生成 1-{3-[3-tert-Butylsulfanyl-1-(4-chloro-benzyl)-5-isopropyl-1H-indol-2-yl]-2,2-dimethyl-propyl}-1-hydroxy-urea
  参考文献：
  名称：

  O-alkylcarboxylate oxime and N-hydroxyurea analogs of substituted indole leukotriene biosynthesis inhibitors

  摘要：

  Reference FLAP inhibitors 1 and 2 were converted into the corresponding O-acetic acid oxime congeners 8 and 11a, respectively, resulting in potent, orally active, leukotriene biosynthesis inhibitors. An attempt to create a dual FLAP and direct 5-LO inhibitor by replacing the carboxylate group in 1 with the N-hydroxyurea pharmacophore did not provide superior inhibitors. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00271-5

文献信息

• O-alkylcarboxylate oxime and N-hydroxyurea analogs of substituted indole leukotriene biosynthesis inhibitors
  作者：Keith W. Woods、Clint D.W. Brooks、Robert G. Maki、Karen E. Rodriques、Jennifer B. Bouska、Patrick Young、Randy L. Bell、George W. Carter

  DOI：10.1016/s0960-894x(96)00271-5

  日期：1996.7

  Reference FLAP inhibitors 1 and 2 were converted into the corresponding O-acetic acid oxime congeners 8 and 11a, respectively, resulting in potent, orally active, leukotriene biosynthesis inhibitors. An attempt to create a dual FLAP and direct 5-LO inhibitor by replacing the carboxylate group in 1 with the N-hydroxyurea pharmacophore did not provide superior inhibitors. Copyright (C) 1996 Elsevier Science Ltd